Latest Loan Repayment News

8common Limited posted positive EBITDA and net profit before tax in Q4 FY26, secured a major multi-year contract with the Australian Taxation Office, and fully repaid its loan facility.

Sheffield Resources has negotiated further waivers and deferrals on key loan repayments for its Thunderbird Mineral Sands Mine, extending relief on obligations due through mid-2026. However, the outcome of ongoing debt restructuring talks remains uncertain.

Right Resources has locked in a second tranche of A$755,000 in non-dilutive R&D funding for FY2026, boosting its collaboration with the University of Tasmania's CODES to deepen understanding of mineral systems in the Tumbarumba district.

Beonic Ltd has fully subscribed the shortfall placement from its recent pro-rata entitlement offer, with nearly 18 million shares set for issuance early next month.

AFC Group Holdings reported a sharp 78% drop in revenue to NZ$161,000 and a net loss of NZ$818,000 for FY2026, but secured shareholder backing and plans to expand its wine portfolio and distribution reach.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.

Nex Metals Explorations and the Wangkatja Tjungula Aboriginal Corporation have formalised a joint venture to combine WTAC’s capital and cultural knowledge with Nex Metals’ technical expertise to pursue gold projects in Western Australia.

Metgasco has obtained a A$500,000 bridging loan at 10% interest to cover immediate capital needs while advancing a broader debt restructuring plan.

Careteq Limited has cleared $125,000 in director and company secretary loans a month ahead of schedule, using proceeds from a recent $2.2 million capital raising. This move strengthens the healthtech firm’s balance sheet and removes related-party debt ahead of maturity.

Critical Resources Limited (ASX:CRR) has initiated a pro-rata entitlement offer of Loyalty Options priced at $0.001 each, aiming to raise $319,410 and potentially $2.56 million upon exercise. The offer underscores significant dilution and operational risks amid ongoing exploration and legal challenges.

Mesoblast Limited posted US$30.3 million in net revenues for Ryoncil® in Q3 2026, hitting key clinical milestones and securing new technology licenses that could boost its next-generation cell therapies.